Skip to main content
S&P 5007,561.67-0.40%DOW52,347.55+0.10%NASDAQ25,136.27-0.91%BTC$68,258.00-3.68%ETH$1,927.42-4.09%GOLD$3,887.60+0.06%OIL$88.92+0.20%
Smart Investors Daily
SID Premium
SRx Health Solutions Inc. logo

NYSE · SRXH

SRx Health Solutions Inc.

Healthcare · Drug Manufacturers - General

$0.95

Up+$0.01 (+1.15%)

Updated Nov 15, 2026, 2:42 AM

SID Score

3.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
12.92M
P/E ratio
-0.67
Dividend yield
5.25%
52-week range
$0.71 – $42.61
Volume
145.91K
Avg. volume
892.09K

Price performance · SRXH

SRXH price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 13, 2026

SRXH closed at $0.95 after 20 trading sessions, down 17.23% for the selected period.

Last close
$0.95
Period change
-17.23%
Period low
$0.80
Period high
$1.15
Daily close
View OHLC price history
SRXH OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 13, 2026$0.9471$0.9745$0.9125$0.9518145.91K
Nov 12, 2026$0.90$1.02$0.90$0.941535.52K
Nov 11, 2026$0.9183$0.945$0.88$0.88222.63K
Nov 10, 2026$0.8886$0.97$0.851$0.943399.59K
Nov 9, 2026$0.82$0.91$0.7102$0.87786.65K
Nov 6, 2026$0.8084$0.8381$0.79$0.8116287.54K
Nov 5, 2026$0.88$0.88$0.775$0.80559.98K
Nov 4, 2026$0.92$0.9785$0.88$0.8871339.94K
Nov 3, 2026$0.9773$0.9915$0.8697$0.9648352.75K
Nov 2, 2026$0.99$1.08$0.9415$0.9698512.86K
Oct 30, 2026$0.97$1.05$0.85$1.011.13M
Oct 29, 2026$1.04$1.07$1.00$1.01287.32K
Oct 28, 2026$1.09$1.0931$1.03$1.04175.5K
Oct 27, 2026$1.04$1.10$1.03$1.08278.49K
Oct 26, 2026$1.00$1.0999$0.995$1.04693.55K
Oct 23, 2026$1.08$1.10$1.0467$1.07391.44K
Oct 22, 2026$1.07$1.12$1.04$1.09472.67K
Oct 21, 2026$1.14$1.15$1.10$1.10370.25K
Oct 20, 2026$1.15$1.16$1.10$1.14245.37K
Oct 19, 2026$1.19$1.30$1.14$1.15377.85K

Latest SRXH news

The latest Smart Investors Daily articles mentioning SRXH.

Stock researchCompany · Overview

SRXH research

Overview

Company profile and research snapshot.

Company profile

SRX HealthSolutions Inc operates the continuing pet health and wellness business under the Halo brand, offering premium and super-premium foods, treats, toppers, chews, dental products and supplements for dogs and cats. The company provides high-quality pet products formulated to meet high-quality sourcing and nutritional standards and produced through co-manufacturing relationships. Its Consumer Products segment includes the legacy Halo pet food business with premium products such as dry kibble, wet food, freeze-dried raw food, treats and toppers. Products are sold across e-commerce platforms such as Amazon and Chewy, select retail partners, and international distributors, with operations mainly in the United States, Taiwan and other markets.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 30, 2026

SRX Global Provides Update on Balance Sheet and Share Buyback

NORTH PALM BEACH, Fla., Oct. 30, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today is providing shareholders with an update on its balance sheet and share buyback. As of October 30, 2026, the Company has approximately $34 million in aggregate cash, cash equivalents, restricted cash and short-term U

Yahoo · Oct 8, 2026

SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX Platform

New platform to be launched with managers from Millennium Management, Balyasny and Citadel, designed to enable the next generation of proprietary traders under Eric Jackson’s leadershipNORTH PALM BEACH, Fla., Oct. 08, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced an initial investment

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By